Hyloris Pharmaceuticals SA(DE:52U)
€4.16+-0.32 (+22.71%)
DE:52U
Hyloris Pharmaceuticals SA Revenue
€4.16
At close:+-0.32 (+22.71%)
Hyloris Pharmaceuticals SA (52U) Revenue
6 Followers
Hyloris Pharmaceuticals SA Revenue
Hyloris Pharmaceuticals SA had a revenue of 2.30M in the quarter ending Dec 31, 2025, with 0.00%. This bring the company's revenue in the last twelve months to 7.94M, Decreased 4.81%. In the fiscal year ending Dec 31, 2025, Hyloris Pharmaceuticals SA had annual revenue of 7.21M with -28.23% growth.
- Revenue (ttm)
- 7.94M
- Revenue Growth
- 21.33%
- P/S Ratio
- 16.40
- Revenue/Employee
- EUR 133,463
- Employees
- 54
- Market Cap
- EUR 118.16M
Revenue Chart
Hyloris Pharmaceuticals SA Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.21M | -2.83M | -28.23% |
| Dec 31, 2024 | 10.04M | 7.96M | 381.17% |
| Dec 31, 2023 | 2.09M | -864.00K | -29.28% |
| Dec 31, 2022 | 2.95M | -145.00K | -4.68% |
| Dec 31, 2021 | 3.10M | 2.92M | 1669.14% |
| Dec 31, 2020 | 175.00K | 84.00K | 92.31% |
| Dec 31, 2019 | 91.00K | 0.00 | 0.00% |
| Dec 31, 2018 | 91.00K | -122.00K | -57.28% |
| Dec 31, 2017 | 213.00K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.